Result of AGM
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your PRTC notes
The Annual General Meeting of PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech Health" or the "Company") was held at 11 a.m. EDT/4 p.m. BST on Monday, June 16, 2025.
All of the resolutions proposed at the Annual General Meeting were duly passed by the shareholders on a poll. The results of the poll, incorporating the proxy votes lodged in advance of the meeting, are set out below.
| Resolutions | For | % | Against | % | Withheld | Total votes cast |
|---|---|---|---|---|---|---|
| 001. To approve the Company's Annual Report and Accounts for year ended 31 December 2024 | 161,252,066 | 99.97% | 43,159 | 0.03% | 43,897 | 161,295,225 |
| 002. To approve the Directors' Remuneration Report | 87,191,034 | 72.49% | 33,087,512 | 27.51% | 41,060,576 | 120,278,546 |
| 003. To re-elect Ms. Sharon Barber-Lui as a Director | 161,168,598 | 99.90% | 165,990 | 0.10% | 4,534 | 161,334,588 |
| 004. To re-elect Dr. Bharatt Chowrira as a Director | 159,345,453 | 98.77% | 1,989,135 | 1.23% | 4,534 | 161,334,588 |
| 005. To elect Dr. Michele Holcomb as a Director | 159,890,727 | 99.90% | 153,630 | 0.10% | 1,294,765 | 160,044,357 |
| 006. To re-elect Dr. Raju Kucherlapati as a Director | 146,615,269 | 90.88% | 14,717,819 | 9.12% | 6,034 | 161,333,088 |
| 007. To re-elect Dr. John LaMattina as a Director | 144,341,297 | 89.47% | 16,993,291 | 10.53% | 4,534 | 161,334,588 |
| 008. To re-elect Dr. Robert Langer as a Director | 153,961,298 | 95.43% | 7,373,290 | 4.57% | 4,534 | 161,334,588 |
| 009. To re-elect Ms. Kiran Mazumdar-Shaw as a Director | 107,562,883 | 72.65% | 40,486,567 | 27.35% | 13,289,672 | 148,049,450 |
| 010. To reappoint PricewaterhouseCoopers LLP as Auditors of the Company | 161,186,429 | 99.93% | 110,554 | 0.07% | 42,139 | 161,296,983 |
| 011. To authorize the Audit Committee to determine the Auditors' remuneration | 161,209,226 | 99.92% | 123,862 | 0.08% | 6,034 | 161,333,088 |
| 012. To authorize the allotment of shares | 159,323,565 | 99.08% | 1,471,794 | 0.92% | 543,763 | 160,795,359 |
| 013. To disapply pre-emption rights | 159,120,011 | 98.63% | 2,216,077 | 1.37% | 3,034 | 161,336,088 |
| 014. To further disapply pre-emption rights for acquisitions and specified capital investments. | 157,494,464 | 97.95% | 3,301,394 | 2.05% | 543,264 | 160,795,858 |
| 015. To authorize market purchase of own shares | 159,970,124 | 99.15% | 1,365,463 | 0.85% | 3,535 | 161,335,587 |
| 016. To authorize general meetings to be called on not less than 14 clear days' notice | 161,167,825 | 99.91% | 148,763 | 0.09% | 22,534 | 161,316,588 |
While all Resolutions were passed with significant majorities, the Board notes that Resolutions 2 and 9 received less than 80% of votes cast in favor.
The Board has consistently taken steps to proactively engage with shareholders on remuneration and governance, including during 2024 and 2025. Consistent with prior practice, the Board will continue to engage with shareholders in the periods ahead and remains committed to maintaining open and constructive dialogue. The Company will provide an update on engagement within six months of today's Annual General Meeting, in accordance with the UK Corporate Governance Code 2024.
Notes:
- As at June 16, 2025, the number of outstanding shares in the Company was 240,254,449 ordinary shares, which was the total number of shares entitling the holders to attend and vote for or against all the resolutions at the AGM. In accordance with the Company's Articles of Association, on a poll every member present in person or by proxy has one vote for every share held.
- The full text of the resolutions may be found in the Notice of the Annual General Meeting, copies of which are available on both the Company's website https://investors.puretechhealth.com/financials-filings/reports and on the National Storage Mechanism.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.